ANGANY
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
873 Rue Saint-jean Ste 200, Quebec, Queb...Phone Number
+33 232590580Website
www.angany.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ANGANY
ANGANY is a private clinical-stage biotechnology company focused on developing innovative allergy therapeutics aimed at helping individuals with allergic asthma build a protective immune response against specific allergens. Their proprietary platform utilizes synthetic biology and a unique self-adjuvant vector, the eBioparticle, to restore immune tolerance and sustainably treat allergies. With a commitment to improving the lives of asthma sufferers, ANGANY's technology has shown promising results in clinical studies, particularly for cat allergy-related asthma. The company also applies its advanced biotechnology to other health fields, including animal health and cancer.Explore more
ANGANY Org Chart
VS
Data Entry Specialist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ANGANY your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if ANGANY had a recent Job posting/layoffs
Funding: Get notified immidiatlly once ANGANY has new funding data
Earning: See what the market has to say on ANGANY recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ANGANY
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
ANGANY, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when ANGANY launches new products
Check out if ANGANY is spiking on competitors!
Check if ANGANY has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined ANGANY as Masked Content
Find more new buyers
Compare Similar Companies to ANGANY
Compare insights from companies similar to ANGANY, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ANGANY is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ANGANY is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ANGANY.
ANGANY Tech Stack
A closer look at the technologies used by ANGANY
See more technologies
Most Recent Scoops
Lateral Move
Executive Move
Board of Directors
New Hire
Executive Move
New Hire
Executive Move
Board of Directors
New Hire
Executive Move
ANGANY News & Media
Favorable Safety Results From First Subjects of ANGANY’s New Biologic Against Allergy to Cats, Clinical Study to Move Ahead
QUEBEC CITY--(BUSINESS WIRE)--Favorable safety results from first subjects of ANGANY’s new biologic against allergy to cats, clinical study to move aheadANGANY Appoints Christine Guillen as CEO, Announces Strengthening of Its Executive Committee
QUEBEC CITY--(BUSINESS WIRE)--ANGANY appoints Christine Guillen as CEO, announces strengthening of its executive committeeAngany Announces Vaccine Candidate to Treat Peanut Allergy
Food Allergy Center of the Massachusetts General Hospital to Begin Preclinical Trial of Angany's Vaccine Candidate to Treat Peanut Allergy. QUEBEC CITY, Nov. 9, 2021 /PRNewswire/ - Angany Inc., announces today that it has entered into a partnering agreement with Dr. Wayne Shreffler, MD,...Angany and Lincoln Diagnostics to Collaborate on Angany's Outreach to US Allergists
Both Companies will be Present at the 2021 ACAAI Annual Scientific Meeting in New Orleans QUEBEC CITY and VAL-DE-REUIL, France and DECATUR, Ill., Nov. 4, 2021 /PRNewswire/ - Louis-Philippe Vézina, CEO of Angany Inc. and Douglas Hein, President of Lincoln Diagnostics Inc. announce the...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding ANGANY
Sign Up For FreeTo access detailed company insights
ANGANY is a private clinical-stage biotechnology company focused on developing innovative allergy therapeutics aimed at helping individuals with allergic asthma build a protective immune response against specific allergens. Their proprietary platform utilizes synthetic biology and a unique self-adjuvant vector, the eBioparticle, to restore immune t... Read More
